Peter Fuming Hu

Has grant

Chief Technologist

University of Maryland School of Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

MEASURING DYSAUTONOMIA FOR THE RAPID DETERMINATION AND PROGRESSION OF TBI

Open Date: 2025-03-14

Close Date: 2028-03-14

Grant: Close

Leishmaniasis in Suriname

Open Date: 2008-09-01

Close Date: 2014-07-10

Articles (16)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

OBJECTIVES: RBC transfusion in anemic patients with sustainable tolerance may cause harm, emphasizing the need for reliable metrics that quantify adequacy (oxygen delivery ≥ demand) and sustainability (oxygen delivery remains adequate without transfusion) of compensatory physiology. Our objective was to identify personalized predictors of anemia intolerance (inadequate and unsustainable physiologic compensation) that predict the likelihood of transfusion benefit. We studied adult trauma subjects at arrival to the emergency department, employing machine learning to evaluate ability of heart rate variability (HRV) to predict subsequent need for clinically indicated significant RBC transfusion. DESIGN: This single-center retrospective cohort study used electronic medical records data from patients admitted to a specialized trauma care hospital between January 2016 and December 2018. SETTING: Trauma resuscitation unit (TRU). PATIENTS: Adult trauma subjects with at least 3 hours of stay in the TRU, without RBC transfusion during the first hour at TRU but, with receipt or nonreceipt of transfusion in the second and/or third hour were included. Availability of electrocardiogram tracings for at least 50% of the first hour of stay in the TRU was also considered for inclusion in the study. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The primary binary outcome variable, a clinically indicated significant transfusion, was if a subject received RBC transfusion or not during the second and third hour stay in the TRU (transfusion vs. no transfusion). Patient clinical information, and HRV parameters generated from a 5-minute electrocardiogram recording during the first hour of admission were used as predictors for predicting transfusion. We evaluated five predefined prediction models for transfusion using random forest algorithm, varying the inclusion of demographic, clinical, trauma, and HRV variables. Model predictive performance was assessed using area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, and Shapley analysis was conducted to identify key contributing variables. The analysis included 269 patients (126: transfusion cohort and 133: no transfusion cohort), who met the inclusion criteria. The model, which included demographic, clinical laboratory, trauma, and HRV variables, had an AUROC of 0.86, a sensitivity of 78%, and a specificity of 75% in predicting transfusion throughout the 3-hour study period. The model with only HRV variables showed comparable predictive performance (AUROC: 0.72) compared with other models with less than 35% false positive and negative rates. Among HRV parameters, lower values of log-transformed very low frequency absolute power predicted transfusion consistently. CONCLUSIONS: HRV parameters collected during the first 5–10 minutes after admission, when combined with basic clinical information that is immediately available upon emergency admission, augmented ability to predict potential for RBC transfusion, suggesting this metric may be incorporated into structured approaches to personalized transfusion decision-making.

Year:

2025

Year:

2025

Year:

2025

Objectives This study aimed to measure the level of phenylacetylglutamine (PAGln) and its correlation with anaemia in ischaemic heart failure (HF) patients. Design A prospective cohort study. Setting The study was conducted at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Participants A total of 89 ischaemic heart failure (IHD) patients confirmed by symptoms, echocardiography and coronary angiography and 75 healthy controls were enrolled (all aged≥18 years). Primary and secondary outcome measures The primary outcome was the association between serum PAGln levels and low haemoglobin (HGB). The secondary outcome was to explore the composite endpoint of cardiovascular death and HF hospitalisations during 1 year of follow-up. Results The PAGln levels were significantly higher in IHD patients compared with the control population (716 (440–1097) vs 411 (202–697) ng/mL, p<0.001). There were 27 IHD patients who had low HGB (27/89). In HF patients with IHD, after adjustment for age and log N-terminal brain natriuretic peptide (NT-proBNP), the tertiles of PAGln were associated with low HGB (OR, 2.610; 95% CI: 1.251 to 5.447; p=0.011). Moreover, during the 1 year follow-up, PAGln levels continued to demonstrate the relationship with HF endpoints (19/73, 26.0%) (HR=3.547, 95% CI: 1.254 to 10.034, p=0.017), even after adjusting for HGB and log NT-proBNP in Cox regression analysis. Conclusions In HF patients with IHD, the elevated PAGln levels were related to reduced HGB. Additionally, the increased PAGln concentrations with low HGB were linked to poor HF endpoint events.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (9)

Shiming Yang

Assistant Professor

University of Maryland

UNITED STATES
View details

Wei Chao

Professor

University of Maryland

UNITED STATES
View details

Allan Doctor

Director

University of Maryland School of Medicine

UNITED STATES
View details

Lujie Karen Chen

Assistant Professor

University of Maryland

UNITED STATES
View details

Geert Meyfroidt

University Hospitals Leuven

BELGIUM
View details

Rishi Ganesan

Staff Paediatric Intensivist

London Health Sciences Centre

CANADA
View details

Neeraj Badjatia

University of Maryland School of Medicine

UNITED STATES
View details

Samuel Galvagno

Associate Professor

University of Maryland School of Medicine

UNITED STATES
View details

Mathangi Gopalakrishnan

-

UNITED STATES
View details